A Study to Compare Efficacy and Safety of Tenofovir Used Alone or in Combination With Pegylated Interferon Alpha-2b in Participants With Chronic Hepatitis B and Elevated Alanine Aminotransferase (MK-4031-384)

NCT01727271 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: Tenofovir
BIOLOGICAL: Pegylated interferon alpha-2b

Sponsor

Merck Sharp & Dohme LLC